These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26341558)

  • 1. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis.
    Li CM; Gocheva V; Oudin MJ; Bhutkar A; Wang SY; Date SR; Ng SR; Whittaker CA; Bronson RT; Snyder EL; Gertler FB; Jacks T
    Genes Dev; 2015 Sep; 29(17):1850-62. PubMed ID: 26341558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of lung adenocarcinoma progression by Nkx2-1.
    Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
    Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
    Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma.
    Li CM; Chen G; Dayton TL; Kim-Kiselak C; Hoersch S; Whittaker CA; Bronson RT; Beer DG; Winslow MM; Jacks T
    Genes Dev; 2013 Jul; 27(14):1557-67. PubMed ID: 23873940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
    Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
    Elife; 2018 Nov; 7():. PubMed ID: 30475207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
    Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
    Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
    Runkle EA; Rice SJ; Qi J; Masser D; Antonetti DA; Winslow MM; Mu D
    J Biol Chem; 2012 Aug; 287(34):28790-801. PubMed ID: 22761434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obligate progression precedes lung adenocarcinoma dissemination.
    Caswell DR; Chuang CH; Yang D; Chiou SH; Cheemalavagu S; Kim-Kiselak C; Connolly A; Winslow MM
    Cancer Discov; 2014 Jul; 4(7):781-9. PubMed ID: 24740995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
    Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
    Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
    Watanabe H; Francis JM; Woo MS; Etemad B; Lin W; Fries DF; Peng S; Snyder EL; Tata PR; Izzo F; Schinzel AC; Cho J; Hammerman PS; Verhaak RG; Hahn WC; Rajagopal J; Jacks T; Meyerson M
    Genes Dev; 2013 Jan; 27(2):197-210. PubMed ID: 23322301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development.
    Watts JA; Zhang C; Klein-Szanto AJ; Kormish JD; Fu J; Zhang MQ; Zaret KS
    PLoS Genet; 2011 Sep; 7(9):e1002277. PubMed ID: 21935353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.
    Wang R; Shi Y; Chen L; Jiang Y; Mao C; Yan B; Liu S; Shan B; Tao Y; Wang X
    Sci Rep; 2015 Dec; 5():17826. PubMed ID: 26658322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.
    Yamaguchi T; Hosono Y; Yanagisawa K; Takahashi T
    Cancer Cell; 2013 Jun; 23(6):718-23. PubMed ID: 23763999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
    Orstad G; Fort G; Parnell TJ; Jones A; Stubben C; Lohman B; Gillis KL; Orellana W; Tariq R; Klingbeil O; Kaestner K; Vakoc CR; Spike BT; Snyder EL
    Dev Cell; 2022 Aug; 57(15):1866-1882.e10. PubMed ID: 35835117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
    Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
    Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
    Caswell DR; Chuang CH; Ma RK; Winters IP; Snyder EL; Winslow MM
    Mol Cancer Res; 2018 Nov; 16(11):1737-1749. PubMed ID: 30002193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeobox Transcription Factor NKX2-1 Promotes
    Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
    Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.